Abstract |
The evidence that calcium plays a role in the etiology, prevention, and treatment of pregnancy-induced hypertension (PIH) is reviewed. The precise factors involved in the pathogenesis of PIH are unclear, but several alterations in calcium metabolism have been identified. Epidemiologic data suggest an inverse correlation between dietary calcium intake and incidence of PIH. Although evidence suggests a possible beneficial effect of supplemental calcium, contradictions persist in clinical trials of pregnant women. Presently, there is insufficient evidence to support routine calcium supplementation of all pregnant women. However, high-risk groups, such as pregnant teens, populations with inadequate calcium intake, and women at risk of developing PIH, may benefit from consuming additional dietary calcium.
|
Authors | L D Ritchie, J C King |
Journal | The American journal of clinical nutrition
(Am J Clin Nutr)
Vol. 71
Issue 5 Suppl
Pg. 1371S-4S
(05 2000)
ISSN: 0002-9165 [Print] United States |
PMID | 10799415
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Calcium, Dietary
(administration & dosage, metabolism)
- Dietary Supplements
- Eclampsia
(diet therapy, etiology, prevention & control)
- Female
- Humans
- Hypertension
(diet therapy, etiology, prevention & control)
- Infant, Newborn
- Pregnancy
- Pregnancy Complications, Cardiovascular
(diet therapy, etiology, prevention & control)
- Pregnancy Outcome
|